Annual CFF
$82.41 M
+$80.79 M+5002.54%
December 31, 2023
Summary
- As of February 7, 2025, TNGX annual cash flow from financing activities is $82.41 million, with the most recent change of +$80.79 million (+5002.54%) on December 31, 2023.
- During the last 3 years, TNGX annual CFF has risen by +$1.52 million (+1.88%).
- TNGX annual CFF is now -76.94% below its all-time high of $357.32 million, reached on December 31, 2021.
Performance
TNGX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$2.40 M
+$1.09 M+83.22%
September 30, 2024
Summary
- As of February 7, 2025, TNGX quarterly cash flow from financing activities is $2.40 million, with the most recent change of +$1.09 million (+83.22%) on September 30, 2024.
- Over the past year, TNGX quarterly CFF has increased by +$935.00 thousand (+63.74%).
- TNGX quarterly CFF is now -99.27% below its all-time high of $327.78 million, reached on September 30, 2021.
Performance
TNGX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$48.16 M
-$77.88 M-61.79%
September 30, 2024
Summary
- As of February 7, 2025, TNGX TTM cash flow from financing activities is $48.16 million, with the most recent change of -$77.88 million (-61.79%) on September 30, 2024.
- Over the past year, TNGX TTM CFF has dropped by -$34.24 million (-41.56%).
- TNGX TTM CFF is now -86.53% below its all-time high of $357.44 million, reached on September 30, 2021.
Performance
TNGX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
TNGX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5002.5% | +63.7% | -41.6% |
| 3 y3 years | +1.9% | +3190.4% | +3265.6% |
| 5 y5 years | +1.9% | +3190.4% | +3265.6% |
TNGX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -76.9% | +5002.5% | -97.0% | +2101.7% | -86.5% | +4875.4% |
| 5 y | 5-year | -76.9% | +5002.5% | -99.3% | +422.0% | -86.5% | +4875.4% |
| alltime | all time | -76.9% | +5002.5% | -99.3% | +422.0% | -86.5% | +4875.4% |
Tango Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.40 M(+83.2%) | $48.16 M(-61.8%) |
| Jun 2024 | - | $1.31 M(-96.9%) | $126.04 M(+0.6%) |
| Mar 2024 | - | $42.98 M(+2829.9%) | $125.31 M(+52.1%) |
| Dec 2023 | $82.41 M(+5002.5%) | $1.47 M(-98.2%) | $82.41 M(+1.2%) |
| Sep 2023 | - | $80.28 M(>+9900.0%) | $81.47 M(+6171.4%) |
| Jun 2023 | - | $586.00 K(+702.7%) | $1.30 M(-9.2%) |
| Mar 2023 | - | $73.00 K(-86.1%) | $1.43 M(-11.4%) |
| Dec 2022 | $1.61 M | $527.00 K(+366.4%) | $1.61 M(+66.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $113.00 K(-84.3%) | $968.00 K(-99.7%) |
| Jun 2022 | - | $718.00 K(+179.4%) | $328.63 M(+0.4%) |
| Mar 2022 | - | $257.00 K(-314.2%) | $327.17 M(-8.4%) |
| Dec 2021 | $357.32 M(+341.8%) | -$120.00 K(-100.0%) | $357.32 M(-0.0%) |
| Sep 2021 | - | $327.78 M(<-9900.0%) | $357.44 M(+1104.9%) |
| Jun 2021 | - | -$746.00 K(-102.5%) | $29.66 M(-2.5%) |
| Mar 2021 | - | $30.41 M | $30.41 M |
| Dec 2020 | $80.88 M | - | - |
FAQ
- What is Tango Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Tango Therapeutics?
- What is Tango Therapeutics annual CFF year-on-year change?
- What is Tango Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Tango Therapeutics?
- What is Tango Therapeutics quarterly CFF year-on-year change?
- What is Tango Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Tango Therapeutics?
- What is Tango Therapeutics TTM CFF year-on-year change?
What is Tango Therapeutics annual cash flow from financing activities?
The current annual CFF of TNGX is $82.41 M
What is the all time high annual CFF for Tango Therapeutics?
Tango Therapeutics all-time high annual cash flow from financing activities is $357.32 M
What is Tango Therapeutics annual CFF year-on-year change?
Over the past year, TNGX annual cash flow from financing activities has changed by +$80.79 M (+5002.54%)
What is Tango Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of TNGX is $2.40 M
What is the all time high quarterly CFF for Tango Therapeutics?
Tango Therapeutics all-time high quarterly cash flow from financing activities is $327.78 M
What is Tango Therapeutics quarterly CFF year-on-year change?
Over the past year, TNGX quarterly cash flow from financing activities has changed by +$935.00 K (+63.74%)
What is Tango Therapeutics TTM cash flow from financing activities?
The current TTM CFF of TNGX is $48.16 M
What is the all time high TTM CFF for Tango Therapeutics?
Tango Therapeutics all-time high TTM cash flow from financing activities is $357.44 M
What is Tango Therapeutics TTM CFF year-on-year change?
Over the past year, TNGX TTM cash flow from financing activities has changed by -$34.24 M (-41.56%)